Huisman, Brooke D.
Guan, Ning http://orcid.org/0000-0003-0522-7792
Rückert, Timo http://orcid.org/0000-0003-1433-1372
Garner, Lee
Singh, Nishant K.
McMichael, Andrew J. http://orcid.org/0000-0002-9101-7478
Gillespie, Geraldine M. http://orcid.org/0000-0002-1075-870X
Romagnani, Chiara http://orcid.org/0000-0002-5167-7463
Birnbaum, Michael E. http://orcid.org/0000-0002-2281-3518
Article History
Received: 23 September 2022
Accepted: 13 July 2023
First Online: 9 August 2023
Change Date: 29 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-40946-y
Competing interests
: B.D.H., T.R., C.R., and M.E.B. are listed as inventors on a patent application (PCT/US23/68073) covering peptides identified in this study. M.E.B. is an equity holder in 3T Biosciences, and is a co-founder, equity holder, and consultant of Kelonia Therapeutics and Abata Therapeutics. The remaining authors declare no competing interests.